After a product is approved by the relevant healthcare agency and released into the market, we conduct a follow-up to collect safety-related information, both at national and international levels. In Argentina, this activity is performed by the National Authority for drugs, food and medical technology, or "ANMAT" (Autoridad Nacional de Medicamentos, Alimentos y Tecnología Médica) through its pharmacovigilance (PhV) systems, and also by its manufacturing lab.
In Argentina, this activity is carried out by ANMAT (Drug, Food and Medical Technology Federal Agency) through its Drug Surveyance systems, as well as the pharmaceutical lab that manufactures the product.
It's defined as any response to a drug which is noxious and unintended, which can be caused by the drug itself or by any other factor. Por instante, a headache, rash, vomiting, etc.
In order to use that information as a source of knowledge from which we can take preventive action in the future.
Therefore, Laboratorio Biosintex works closely with heathcare professionals providing them with state-of-the-art products jbesides permanent support, thus protecting patients' safety.
The Adverse Effects report and the suspicious of quality faults help detect issues related to the drug use and keep an updated safety profile of the drugs prescribed to our patients.
COMPLETE THE FORM ONLY FOR MEDICAL PRODUCTS: Ophtalmic line, winter line, skin productos, others.
(1) Adult in charge in case the patient is a minor
(*) FIELDS REQUIRED